Connor Yuen - EGF Theramed Chief Officer
EVAHF Stock | USD 0.21 0.00 0.00% |
Insider
Connor Yuen is Chief Officer of EGF Theramed Health
Phone | 778-331-4303 |
Web | https://www.egftheramedhealth.com |
EGF Theramed Management Efficiency
The company has return on total asset (ROA) of (0.7188) % which means that it has lost $0.7188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.1082) %, meaning that it generated substantial loss on money invested by shareholders. EGF Theramed's management efficiency ratios could be used to measure how well EGF Theramed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
BEc BEc | Cogstate Limited | 52 | |
Thyagarajan Ramachandran | Healthcare Triangle | 48 | |
Kenneth Billard | Cogstate Limited | N/A | |
Louis Deluca | Mitesco | 64 | |
Chris Edgar | Cogstate Limited | N/A | |
Sudish Mogli | Healthcare Triangle | 55 | |
Jenny Lindstrom | Mitesco | 49 | |
Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
BBus CA | Cogstate Limited | N/A | |
Ronald Riewold | Mitesco | 74 | |
Suresh Venkatachari | Healthcare Triangle | 57 | |
Kristi Lane | Healthcare Triangle | N/A | |
Michael Gill | Healthcare Triangle | 46 | |
Darren Watson | Cogstate Limited | N/A | |
Pr BBSc | Cogstate Limited | N/A | |
Lakshmanan Kannappan | Healthcare Triangle | 57 | |
Amy Veroff | Cogstate Limited | N/A | |
Benjamin Bloomfield | Cogstate Limited | N/A | |
Thomas Brodmerkel | Mitesco | 65 | |
Lawrence Diamond | Mitesco | 59 | |
Bradley Case | Mitesco | N/A |
Management Performance
Return On Equity | -2.11 | |||
Return On Asset | -0.72 |
EGF Theramed Health Leadership Team
Elected by the shareholders, the EGF Theramed's board of directors comprises two types of representatives: EGF Theramed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EGF. The board's role is to monitor EGF Theramed's management team and ensure that shareholders' interests are well served. EGF Theramed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EGF Theramed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Connor Yuen, Chief Officer | ||
Usama Chaudhry, CFO Director |
EGF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is EGF Theramed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -2.11 | |||
Return On Asset | -0.72 | |||
Current Valuation | 4.72 M | |||
Shares Outstanding | 10.49 M | |||
Shares Owned By Insiders | 0.09 % | |||
Price To Book | 42.04 X | |||
Gross Profit | (105.22 K) | |||
EBITDA | (1.35 M) | |||
Net Income | (1.35 M) | |||
Cash And Equivalents | 51.98 K |
Currently Active Assets on Macroaxis
Other Information on Investing in EGF Pink Sheet
EGF Theramed financial ratios help investors to determine whether EGF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EGF with respect to the benefits of owning EGF Theramed security.